The impact of magnitude and duration of plasma viremia during analytical treatment interruptions on CD4+ T cell recovery after ART resumption
In our pooled analysis, high peak rebound pVLs and longer duration of viremia did not impair CD4<sup>+</sup> T cell recovery following the resumption of ART, supporting the safety of more flexible ATIs in HIV-1 cure trials.
Authors
- Ole S. Søgaard (ORCID: https://orcid.org/0000-0001-9107-2023)
- Vibeke Klastrup (ORCID: https://orcid.org/0000-0001-7084-4207)
- Jesper Damsgaard Gunst (ORCID: https://orcid.org/0000-0002-3787-0259)
Institutions
- Aarhus University (DK)
- Aarhus University Hospital (DK)
Publication Details
- Journal
- Journal of Virus Eradication
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1016/j.jve.2025.100604
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Aarhus Universitet
- Lundbeckfonden
- Danmarks Frie Forskningsfond
- Health Research Fund of Central Denmark Region